186 related articles for article (PubMed ID: 34450232)
1. Signal transducer and activator of transcription 3 signaling in tumor immune evasion.
Zhang L; Kuca K; You L; Zhao Y; Musilek K; Nepovimova E; Wu Q; Wu W; Adam V
Pharmacol Ther; 2022 Feb; 230():107969. PubMed ID: 34450232
[TBL] [Abstract][Full Text] [Related]
2. Shikonin-mediated PD-L1 degradation suppresses immune evasion in pancreatic cancer by inhibiting NF-κB/STAT3 and NF-κB/CSN5 signaling pathways.
Ruan Z; Liang M; Shang L; Lai M; Deng X; Su X
Pancreatology; 2021 Apr; 21(3):630-641. PubMed ID: 33707115
[TBL] [Abstract][Full Text] [Related]
3. Deoxynivalenol upregulates hypoxia-inducible factor-1α to promote an "immune evasion" process by activating STAT3 signaling.
Zhang L; Wang X; Nepovimova E; Wu Q; Wu W; Kuca K
Food Chem Toxicol; 2023 Sep; 179():113975. PubMed ID: 37517547
[TBL] [Abstract][Full Text] [Related]
4. The role of hypoxia-inducible factor 1 in tumor immune evasion.
You L; Wu W; Wang X; Fang L; Adam V; Nepovimova E; Wu Q; Kuca K
Med Res Rev; 2021 May; 41(3):1622-1643. PubMed ID: 33305856
[TBL] [Abstract][Full Text] [Related]
5. Signal transducer and activator of transcription 3 is required for hypoxia-inducible factor-1alpha RNA expression in both tumor cells and tumor-associated myeloid cells.
Niu G; Briggs J; Deng J; Ma Y; Lee H; Kortylewski M; Kujawski M; Kay H; Cress WD; Jove R; Yu H
Mol Cancer Res; 2008 Jul; 6(7):1099-105. PubMed ID: 18644974
[TBL] [Abstract][Full Text] [Related]
6. The Multifaceted Role of STAT3 in NK-Cell Tumor Surveillance.
Witalisz-Siepracka A; Klein K; Zdársky B; Stoiber D
Front Immunol; 2022; 13():947568. PubMed ID: 35865518
[TBL] [Abstract][Full Text] [Related]
7. Curcumol inhibits the expression of programmed cell death-ligand 1 through crosstalk between hypoxia-inducible factor-1α and STAT3 (T705) signaling pathways in hepatic cancer.
Zuo HX; Jin Y; Wang Z; Li MY; Zhang ZH; Wang JY; Xing Y; Ri MH; Jin CH; Xu GH; Piao LX; Ma J; Jin X
J Ethnopharmacol; 2020 Jul; 257():112835. PubMed ID: 32278762
[TBL] [Abstract][Full Text] [Related]
8. Regulation of PD-L1: a novel role of pro-survival signalling in cancer.
Chen J; Jiang CC; Jin L; Zhang XD
Ann Oncol; 2016 Mar; 27(3):409-16. PubMed ID: 26681673
[TBL] [Abstract][Full Text] [Related]
9. Fructose-1,6-bisphosphatase loss modulates STAT3-dependent expression of PD-L1 and cancer immunity.
Wang B; Zhou Y; Zhang J; Jin X; Wu H; Huang H
Theranostics; 2020; 10(3):1033-1045. PubMed ID: 31938049
[No Abstract] [Full Text] [Related]
10. IL20RA signaling enhances stemness and promotes the formation of an immunosuppressive microenvironment in breast cancer.
Gao W; Wen H; Liang L; Dong X; Du R; Zhou W; Zhang X; Zhang C; Xiang R; Li N
Theranostics; 2021; 11(6):2564-2580. PubMed ID: 33456560
[No Abstract] [Full Text] [Related]
11. Dexamethasone suppresses immune evasion by inducing GR/STAT3 mediated downregulation of PD-L1 and IDO1 pathways.
Xiang Z; Zhou Z; Song S; Li J; Ji J; Yan R; Wang J; Cai W; Hu W; Zang L; Zhu Z; Zhang Z; Li M; Yu Y
Oncogene; 2021 Aug; 40(31):5002-5012. PubMed ID: 34175886
[TBL] [Abstract][Full Text] [Related]
12. Hypoxia Impairs NK Cell Cytotoxicity through SHP-1-Mediated Attenuation of STAT3 and ERK Signaling Pathways.
Teng R; Wang Y; Lv N; Zhang D; Williamson RA; Lei L; Chen P; Lei L; Wang B; Fu J; Liu X; He A; O'Dwyer M; Hu J
J Immunol Res; 2020; 2020():4598476. PubMed ID: 33123602
[TBL] [Abstract][Full Text] [Related]
13. A perylene derivative regulates HIF-1α and Stat3 signaling pathways.
Chen H; Guan Y; Yuan G; Zhang Q; Jing N
Bioorg Med Chem; 2014 Feb; 22(4):1496-505. PubMed ID: 24485121
[TBL] [Abstract][Full Text] [Related]
14. GRIM-19 repressed hypoxia-induced invasion and EMT of colorectal cancer by repressing autophagy through inactivation of STAT3/HIF-1α signaling axis.
Zhang J; Chu D; Kawamura T; Tanaka K; He S
J Cell Physiol; 2019 Aug; 234(8):12800-12808. PubMed ID: 30537081
[TBL] [Abstract][Full Text] [Related]
15. Ibrutinib modulates the immunosuppressive CLL microenvironment through STAT3-mediated suppression of regulatory B-cell function and inhibition of the PD-1/PD-L1 pathway.
Kondo K; Shaim H; Thompson PA; Burger JA; Keating M; Estrov Z; Harris D; Kim E; Ferrajoli A; Daher M; Basar R; Muftuoglu M; Imahashi N; Alsuliman A; Sobieski C; Gokdemir E; Wierda W; Jain N; Liu E; Shpall EJ; Rezvani K
Leukemia; 2018 Apr; 32(4):960-970. PubMed ID: 28972595
[TBL] [Abstract][Full Text] [Related]
16. Converged Rab37/IL-6 trafficking and STAT3/PD-1 transcription axes elicit an immunosuppressive lung tumor microenvironment.
Kuo IY; Yang YE; Yang PS; Tsai YJ; Tzeng HT; Cheng HC; Kuo WT; Su WC; Chang CP; Wang YC
Theranostics; 2021; 11(14):7029-7044. PubMed ID: 34093869
[No Abstract] [Full Text] [Related]
17. IL6/STAT3 Signaling Orchestrates Premetastatic Niche Formation and Immunosuppressive Traits in Lung.
Jing B; Wang T; Sun B; Xu J; Xu D; Liao Y; Song H; Guo W; Li K; Hu M; Zhang S; Ling J; Kuang Y; Zhang T; Zhou BP; Yao F; Deng J
Cancer Res; 2020 Feb; 80(4):784-797. PubMed ID: 31848193
[TBL] [Abstract][Full Text] [Related]
18. CCR5 Blockade Suppresses Melanoma Development Through Inhibition of IL-6-Stat3 Pathway via Upregulation of SOCS3.
Tang Q; Jiang J; Liu J
Inflammation; 2015 Dec; 38(6):2049-56. PubMed ID: 26047948
[TBL] [Abstract][Full Text] [Related]
19. Communication between EMT and PD-L1 signaling: New insights into tumor immune evasion.
Jiang Y; Zhan H
Cancer Lett; 2020 Jan; 468():72-81. PubMed ID: 31605776
[TBL] [Abstract][Full Text] [Related]
20. A TCM formula comprising Sophorae Flos and Lonicerae Japonicae Flos alters compositions of immune cells and molecules of the STAT3 pathway in melanoma microenvironment.
Liu YX; Bai JX; Li T; Fu XQ; Guo H; Zhu PL; Chan YC; Chou JY; Yin CL; Li JK; Wang YP; Chen YJ; Yu ZL
Pharmacol Res; 2019 Apr; 142():115-126. PubMed ID: 30797070
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]